Concepedia

Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients

Thorsten Heilmann, Florian Vondung, Christoph Borzikowsky, Silke Szymczak, Sandra Krüger, İbrahim Alkatout, Antonia Wenners, M. Bauer, Christoph Röcken, Nicolaì Maass,

Journal of Molecular Medicine · 2019 · 12 citations · 37 references

DOI

Concepts

References

37

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

, , +14

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

Henning Walczak, Robert E. Miller, K. Ariail et al. · Nature Medicine · 1999 · 2.5K citations

, , +12

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.4K citations · Full text

, , +17

Safety and antitumor activity of recombinant soluble Apo2 ligand

Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text

, , +17

TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL

Henning Walczak · The EMBO Journal · 1997 · 1.1K citations · Full text

, , +12